Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Celgene Revlimid PDUFA Date Extended to January

Related Content

Celgene’s Revlimid Phase II Data Sufficient For Full Approval In MDS

Sep 14 2005

Revlimid Multiple Myeloma Trial Paused Due to Blood Clots

Sep 28 2005

Additional Topics

BioPharmaceutical

More from Archive

More from Pink Sheet

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window